Bond Merck & CIE 0.5% ( XS1513055555 ) in EUR

Issuer	Merck & CIE
Market price	100 % ▲
Country	United States
ISIN code	XS1513055555 ( in EUR )
Interest rate	0.5% per year ( payment 1 time a year)
Maturity	01/11/2024 - Bond has expired
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	100 000 EUR
Total amount	500 000 000 EUR
Detailed description	Merck & Co., Inc. is a leading global biopharmaceutical company that discovers, develops, manufactures, and markets a broad range of innovative health solutions, including medicines, vaccines, and animal health products. A detailed analysis of the bond identified by ISIN XS1513055555 reveals key characteristics of a matured debt instrument issued by Merck & Co. Merck & Co, a prominent global pharmaceutical company headquartered in the United States, is renowned for its significant contributions to healthcare through innovative medicines, vaccines, and animal health products, maintaining a substantial presence in global financial markets and frequently utilizing debt instruments to finance its expansive operations, research and development, and strategic initiatives. This particular bond, denominated in Euros (EUR) and originating from the United States, carried an annual interest rate of 0.5% and represented a total issuance size of ?500,000,000, with a minimum purchase threshold set at ?100,000. It had a precisely defined maturity date of November 1, 2024, at which point its market price was observed at 100% of its face value, reflecting its full repayment expectation. As of its maturity date, this obligation has successfully concluded its term and has been fully repaid to its holders, concluding its lifecycle as a tradable financial asset.